09/25/2008

GNI Announces Strategy for Seeking Early Conditional Approval of F647 for the treatment of Idiopathic Pulmonary Fibrosis in China

09/10/2008

Notice of Cancellation of the 3rd Stock Issuance in Private Placement Offerings

09/01/2008

Notice of the Resignation of the Auditor and the Inauguration of the Officer

08/18/2008

Notice of Payment for Allocation of New Shares to a Third Party

08/14/2008

Notice of Amendment of Earnings Forecast

08/13/2008

Notice of Cancellation of the 2nd Stock Issuance in Private Placement Offerings

08/06/2008

Amendment of Notification of Major Shareholder Change

08/01/2008

Announcement of Changes in Titles of the Management

08/01/2008

GNI Announces Restructuring to Streamline Operation and to Reduce Cost; CEO Luo Succeeds President

08/01/2008

Notice of Stock Issuance in Private Placement Offering

07/29/2008

Amendment of Share Purchase Commitment Agreement with Evo Fund

07/25/2008

Notification of major shareholder Change

07/22/2008

Notice of Granting Stock Option to Board of Directors and Corporate Auditors

07/15/2008

GNI Announces the Conclusion of the Share Purchase Agreement

06/19/2008

GNI Signs Binding Term Sheet to Raise Capital